Enrica Bach

Leipzig, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells.

Clonal Hematopoiesis does not influence manufacturing of Chimeric Antigen Receptor (CAR) T-Cells.

Journal: Bone marrow transplantation

Published: February 19, 2026

Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis.

Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Published: October 07, 2025

Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells.

Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells.

Journal: Transfusion

Published: May 19, 2025

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma.

A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma.

Journal: Cancer cell

Published: May 05, 2025

Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.

Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.

Journal: HemaSphere

Published: February 13, 2025

Extracorporeal photopheresis-New insights into an old procedure.

Extracorporeal photopheresis-New insights into an old procedure.

Journal: Transfusion medicine (Oxford, England)

Published: December 14, 2024

Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

Journal: Blood cancer discovery

Published: May 09, 2024

Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.

Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 18, 2024

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.

Journal: Leukemia

Published: September 28, 2023

Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.

Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.

Journal: Transfusion

Published: June 14, 2023

Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.

Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.

Journal: Nature cancer

Published: February 24, 2023

Analysis of stem cell collections in adult patients with Ewing sarcoma.

Analysis of stem cell collections in adult patients with Ewing sarcoma.

Journal: Transfusion

Published: March 18, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026